- Aug 2021
-
twitter.com twitter.com
-
Leif Erik Sander. “1/6 Our Study Comparing Reactogenicity & Immunogenicity of Homologous (2xBNT/Pfizer) vs Heterologous (AZ/ChAdOx +BNT) Vaccination Is Available Https://Medrxiv.Org/Content/10.1101/2021.05.19.21257334v2 Great Team Effort @vmcorman #FlorianKurth #DavidHillus #TatjanaSchwarz #PinkusToberLau et al. @ChariteBerlin 🧵 Https://T.Co/4zXfY4rV9c.” Tweet. @Sander_Lab (blog), June 2, 2021. https://twitter.com/Sander_Lab/status/1400178343123853321.
-
- Jun 2021
-
www.thelancet.com www.thelancet.com
-
Duarte-Salles, T., & Prieto-Alhambra, D. (2021). Heterologous vaccine regimens against COVID-19. The Lancet, S0140673621014422. https://doi.org/10.1016/S0140-6736(21)01442-2
-
-
www.sciencedirect.com www.sciencedirect.com
-
Borobia, A. M., Carcas, A. J., Pérez-Olmeda, M., Castaño, L., Bertran, M. J., García-Pérez, J., Campins, M., Portolés, A., González-Pérez, M., García Morales, M. T., Arana-Arri, E., Aldea, M., Díez-Fuertes, F., Fuentes, I., Ascaso, A., Lora, D., Imaz-Ayo, N., Barón-Mira, L. E., Agustí, A., … Torvisco, J. M. (2021). Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): A multicentre, open-label, randomised, controlled, phase 2 trial. The Lancet, S0140673621014203. https://doi.org/10.1016/S0140-6736(21)01420-3
-